Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. ResMed Inc.
  6. Summary
    RMD   US7611521078

RESMED INC.

(RMD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
259.74(c) 264.24(c) 266.03(c) 269.73(c) 271.8(c) Last
298 469 503 949 580 065 284 268 350 322 Volume
-0.03% +1.73% +0.68% +1.39% +0.77% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 3 116 M - -
Net income 2021 455 M - -
Net Debt 2021 429 M - -
P/E ratio 2021 86,5x
Yield 2021 0,58%
Sales 2022 3 540 M - -
Net income 2022 804 M - -
Net cash position 2022 53,6 M - -
P/E ratio 2022 48,8x
Yield 2022 0,70%
Capitalization 39 552 M 39 552 M -
EV / Sales 2021 12,8x
EV / Sales 2022 11,2x
Nbr of Employees 7 770
Free-Float 77,0%
More Financials
Company
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. The Company operates through two segments: Sleep and... 
More about the company
Ratings of ResMed Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about RESMED INC.
07/28Today on Wall Street: Better-than-expected earnings ahead of the Fed
07/28RESMED : Jefferies Upgrades ResMed to Hold From Underperform, Adjusts Price Targ..
MT
07/28ANALYST RECOMMENDATIONS : Flutter, Hasbro, MGM Resort, Microsoft Vodafone...
07/27RESMED : RBC Raises Price Target on ResMed to $238 From $223, Citing Positive Im..
MT
07/27NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
07/26RESMED : Needham Hikes Price Target for ResMed to $285 From $267, Maintains Buy ..
MT
07/26RESMED : JPMorgan Downgrades ResMed to Neutral from Overweight, Adjusts Price Ta..
MT
07/19Australian shares end lower as virus surge raises economic growth worries
RE
07/16Australia shares log best week in six as BHP hits record high
RE
07/15ResMed to Report Fourth Quarter Fiscal 2021 Earnings on August 5, 2021
GL
07/14RESMED : Initiated at Underperform by RBC as Firm Calls Consensus Estimates Too ..
MT
07/13INSIDER TRENDS : ResMed Insider Continues 90-Day Selling Trend
MT
07/07INSIDER TRENDS : Insider Adds to Selling Trend at ResMed
MT
07/06INSIDER TRENDS : ResMed Insider Extends 90-Day Selling Trend
MT
07/02INSIDER TRENDS : Insider Sales Continue 90-Day Trend at ResMed
MT
More news
News in other languages on RESMED INC.
06/21Hoy en Wall Street: Una serie de discursos oficiales de la Fed está en camino
05/03MÄRKTE USA/Wall Street vor Powell-Rede uneinheitlich
05/03MÄRKTE USA/Starker Start in den Mai
05/03MÄRKTE USA/Etwas fester erwartet - Anleger müssen abwägen
04/09Nyxoah boekt voor het eerst omzet
More news
Analyst Recommendations on RESMED INC.
More recommendations
Chart RESMED INC.
Duration : Period :
ResMed Inc. Technical Analysis Chart | RMD | US7611521078 | MarketScreener
Technical analysis trends RESMED INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 271,80 $
Average target price 236,67 $
Spread / Average Target -12,9%
EPS Revisions
Managers and Directors
Michael J. Farrell Chief Executive Officer & Director
Robert Andrew Douglas President & Chief Operating Officer
Brett A. Sandercock Chief Financial Officer
Peter C. Farrell Non-Executive Chairman
Carlos M. Nunez Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
RESMED INC.27.87%39 552
DANAHER CORPORATION33.92%212 378
THERMO FISHER SCIENTIFIC15.94%212 239
INTUITIVE SURGICAL, INC.21.19%117 734
SIEMENS HEALTHINEERS AG32.63%74 161
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-8.37%73 440